Status of P2Y12 treatment must be considered in evaluation of myocardial ischaemia/reperfusion injury

Affiliations

¹ Department of Physiology and Cell Biology and Medicine, University of South Alabama College of Medicine, Mobile, AL, USA mcohen@southalabama.edu.
² Department of Physiology, Emeritus, University of South Alabama College of Medicine, Mobile, AL, USA.

Comment

Michael V Cohen et al. Cardiovasc Res. 2015.

. 2015 Apr 1;106(1):8.

doi: 10.1093/cvr/cvv051. Epub 2015 Feb 27.

¹ Department of Physiology and Cell Biology and Medicine, University of South Alabama College of Medicine, Mobile, AL, USA mcohen@southalabama.edu.
² Department of Physiology, Emeritus, University of South Alabama College of Medicine, Mobile, AL, USA.

No abstract available

Comment in

Platelet inhibitors influence cardioprotection: importance in preclinical study design: reply.
Lecour S, Schulz R, Ferdinandy P, Hausenloy DJ. Lecour S, et al. Cardiovasc Res. 2015 Apr 1;106(1):8. doi: 10.1093/cvr/cvv052. Epub 2015 Feb 27. Cardiovasc Res. 2015. PMID: 25724888 No abstract available.

ESC working group cellular biology of the heart: position paper: improving the preclinical assessment of novel cardioprotective therapies.
Lecour S, Bøtker HE, Condorelli G, Davidson SM, Garcia-Dorado D, Engel FB, Ferdinandy P, Heusch G, Madonna R, Ovize M, Ruiz-Meana M, Schulz R, Sluijter JP, Van Laake LW, Yellon DM, Hausenloy DJ. Lecour S, et al. Cardiovasc Res. 2014 Dec 1;104(3):399-411. doi: 10.1093/cvr/cvu225. Epub 2014 Oct 24. Cardiovasc Res. 2014. PMID: 25344369 Free PMC article. Review.